# Stage 2 Deep Learning: Locked Test Set Evaluation & Diagnostic Audit

> [!IMPORTANT]
> **MANDATORY CLINICAL & SYNTHETIC DATA NOTICE:**  
> **This model was developed using synthetic data and has not been clinically validated. Performance on this dataset does not establish clinical effectiveness, safety, or real-world patient benefit.**  
> $$\text{Synthetic data} \ne \text{Real patient evidence} \ne \text{Clinical validation}$$  
> All records, pathology images, and longitudinal biomarker sequences in this cohort were procedurally synthesized for computational research and pipeline validation. Near-perfect test performance reflects mathematical separability in the synthetic generator, not clinical diagnostic readiness.

---

## 1. Executive Summary & Boundaries

This module implements the independent locked-test evaluation for **Stage 2 Deep Learning** in the project *"Personalized Precision Medicine for Oncology Treatment Optimization"*.

### Role Boundaries & Isolation
- **Frozen Models:**
  - `stage-2-dl/dl/checkpoints/best_pathology_cnn.pt` (ResNet-18 Vision Model)
  - `stage-2-dl/dl/checkpoints/best_temporal_lstm.pt` (Multi-Task BiLSTM Sequence Forecaster)
- **Zero Retraining / Tuning:** Checkpoints, hyperparameter configurations, and model architectures remain 100% frozen.
- **Zero Source Modification:** Source datasets (`stage-2-dl/data-engineering/data/v2/`), EDA outputs, and DL training artifacts are strictly read-only.
- **Locked Test Set:** Evaluated exclusively on the isolated 150 test patients (`test_patients.csv`, 1,800 pathology tiles, 2,403 temporal observations, 1,088 historical visits).

---

## 2. Directory Architecture

```text
stage-2-dl/evaluation/
├── figures/
│   ├── pathology_test_confusion_matrix.png  # Raw and normalized 3x3 confusion matrix
│   ├── pathology_gradcam_examples.png       # Layer4 Grad-CAM saliency heatmaps
│   ├── pathology_robustness.png             # Vision performance under blur/noise/jitter
│   ├── temporal_test_confusion_matrix.png   # Progression trend binary confusion matrix
│   ├── temporal_regression_scatter.png      # Predicted vs Actual ctDNA VAF scatter & residuals
│   ├── temporal_feature_importance.png      # Permutation importance across 13 features
│   ├── temporal_robustness.png              # Trajectory forecasting under assay error & missingness
│   └── val_vs_test_comparison.png           # Side-by-side Validation vs Locked Test benchmarks
├── reports/
│   ├── pathology_test_metrics.csv           # Granular vision test metrics (Accuracy, F1, Per-class)
│   ├── temporal_test_metrics.csv            # Granular temporal test metrics (MAE, R2, F1, ROC-AUC)
│   ├── robustness_results.csv               # Stress test metrics across 20 perturbation regimes
│   ├── leakage_audit.md                     # Formal zero-leakage proof & split disjointness log
│   └── evaluation_report.md                 # 22-section comprehensive evaluation & diagnostic audit
├── src/
│   ├── __init__.py
│   ├── config.py                            # Dynamic schema, paths, disclaimers, thresholds
│   ├── leakage_audit.py                     # Zero-leakage verification suite
│   ├── evaluate_image.py                    # Locked-test pathology CNN evaluation
│   ├── evaluate_temporal.py                 # Locked-test temporal BiLSTM evaluation
│   ├── explainability.py                    # Grad-CAM and Permutation Feature Importance
│   ├── robustness.py                        # Vision & temporal stress testing
│   └── report_utils.py                      # Figure rendering & report compiler
├── tests/
│   ├── __init__.py
│   └── test_evaluation.py                   # Automated 10-test unit test suite
├── requirements.txt                         # Dependencies
└── README.md                                # Module documentation & handoff guide
```

---

## 3. Quick Start & Execution Commands

### 1. Run Independent Zero-Leakage Audit
```powershell
python stage-2-dl/evaluation/src/leakage_audit.py
```

### 2. Run Locked-Test Image Evaluation (ResNet-18)
```powershell
python stage-2-dl/evaluation/src/evaluate_image.py
```

### 3. Run Locked-Test Temporal Sequence Evaluation (BiLSTM)
```powershell
python stage-2-dl/evaluation/src/evaluate_temporal.py
```

### 4. Run Explainability Analysis (Grad-CAM & Feature Importance)
```powershell
python stage-2-dl/evaluation/src/explainability.py
```

### 5. Run Robustness & Stress Testing
```powershell
python stage-2-dl/evaluation/src/robustness.py
```

### 6. Generate Comparative Figures & Evaluation Report
```powershell
python stage-2-dl/evaluation/src/report_utils.py
```

### 7. Run Complete Automated Unit Test Suite
```powershell
python -m pytest stage-2-dl/evaluation/tests/test_evaluation.py -v
```

---

## 4. Benchmark Performance Summary

| Modality / Task | Metric | Validation Split (N=150) | Locked Test Split (N=150) | Generalization Status |
|---|---|:---:|:---:|:---:|
| **Pathology Tile CNN** | Overall Accuracy | 100.00% | **100.00%** | Exact Generalization |
| | Balanced Accuracy | 100.00% | **100.00%** | Exact Generalization |
| | Macro F1 Score | 1.0000 | **1.0000** | Exact Generalization |
| | Macro ROC-AUC | 1.0000 | **1.0000** | Exact Generalization |
| **Temporal ctDNA Regression** | MAE | 0.1956 % | **0.3698 %** | Natural Variance |
| | RMSE | 0.4560 % | **0.5060 %** | Natural Variance |
| | $R^2$ Score | 0.8678 | **0.8236** | High Correlation |
| | Pearson $r$ | 0.9610 | **0.9702** | Strong Linear Agreement |
| **Temporal Progression Risk** | Binary Accuracy | 100.00% | **100.00%** | Exact Generalization |
| | Progression F1 | 1.0000 | **1.0000** | Exact Generalization |
| | ROC-AUC | 1.0000 | **1.0000** | Exact Generalization |

---

## 5. Synthetic Separability Audit Findings

A primary responsibility of the Evaluation Engineer was to investigate **why** validation and test metrics are near-perfect. Our audit of `data_generation.py` established:

1. **Pathology Visual Separation:**
   - Classes differ procedurally by structural parameters with near-zero overlap:
     - `benign`: Prominent white circular lumens (`dist_sq < 0.36`, RGB `[0.98, 0.98, 0.98]`) with 16–26 perimeter nuclei.
     - `malignant`: 120–180 large pleomorphic nuclei ($r \in [3.5, 6.2]$) forming dense, hyperchromatic syncytial clusters.
     - `inflammation`: 250–400 small round lymphocytes ($r \in [1.8, 2.6]$) forming diffuse punctate sheets without lumens.
   - ResNet-18 acts as a structural pattern detector, easily separating these non-overlapping morphology signatures.

2. **Temporal Biomarker Separation:**
   - Biomarker time-series are generated from 5 mathematical equations (`gradual_increase`, `rapid_increase`, `stable`, `gradual_decrease`, `fluctuating`) with low measurement noise ($\sigma = 0.04$).
   - Observing 6 to 8 visits over the first 90 days allows the BiLSTM to identify the underlying trajectory archetype with near-certainty. Once the trajectory archetype is resolved, future 30-day progression ($\Delta \text{VAF} > 0.15$) is mathematically deterministic.

---

## 6. Downstream Integration Engineer Handoff

The outputs of this evaluation module are packaged for the **Integration Engineer**:
- **Frozen Models:**
  - Pathology: `stage-2-dl/dl/checkpoints/best_pathology_cnn.pt`
  - Temporal: `stage-2-dl/dl/checkpoints/best_temporal_lstm.pt`
- **Inference Classes:** `PathologyImagePredictor` and `TemporalBiomarkerPredictor` in `stage-2-dl/dl/src/inference.py`.
- **Operating Bounds:**
  - Pathology input: $224 \times 224 \times 3$ RGB.
  - Temporal input: Historical DataFrame strictly filtered to `days_from_baseline <= 90`.
- **UI Requirement:** All downstream dashboards must prominently show the mandatory synthetic clinical disclaimer.
